Renibus Therapeutics: Funding, Investors & Team (Sep 2026)
Renibus Therapeutics is a biotech company that is in the clinical stage and aims to improve the results for individuals undergoing cardiothoracic surgery. They have created a range of products that stimulate various cytoprotective pathways, such as organ protection through preconditioning.
Renibus Therapeutics has raised $159M across 4 funding rounds on record, the most recent a Series B of $25.0M announced in Sep 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Renibus Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2023.
Renibus Therapeutics Funding Rounds
Renibus Therapeutics raised $23.0M in an undisclosed round announced in Nov 2022.
7 months later, an undisclosed round of $63.8M was announced in Jun 2023.
1 month later, a Series B of $47.0M was announced in Jul 2023.
2 months later, a Series B of $25.0M was announced in Sep 2023.
Renibus Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Renibus Therapeutics Funding Compared to Other Biotechnology Startups
Renibus Therapeutics' latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Renibus Therapeutics in Biotechnology and Southlake
Companies Similar to Renibus Therapeutics
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Renibus Therapeutics Funding FAQs
What does Renibus Therapeutics do?
Renibus Therapeutics is a biotech company that is in the clinical stage and aims to improve the results for individuals undergoing cardiothoracic surgery. They have created a range of products that stimulate various cytoprotective pathways, such as organ protection through preconditioning.
How much funding has Renibus Therapeutics raised?
Renibus Therapeutics has raised $159M across 4 rounds on record. The most recent is a Series B of $25.0M announced in Sep 2023.
When did Renibus Therapeutics last raise funding?
Renibus Therapeutics' most recent funding round on record is a Series B of $25.0M, announced in Sep 2023.
Who founded Renibus Therapeutics?
FundedIQ lists Alvaro Guillem (Founder), D Jeffrey Keyser (Founder) at Renibus Therapeutics.
Who is the CEO of Renibus Therapeutics?
Frank Stonebanks is listed as CEO at Renibus Therapeutics.
Where is Renibus Therapeutics headquartered?
Renibus Therapeutics is based in Southlake, Texas, United States.
How many employees does Renibus Therapeutics have?
Renibus Therapeutics is in the 11-50 employee band.
How does Renibus Therapeutics' funding compare to other Biotechnology startups?
Renibus Therapeutics' latest round of $25.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Renibus Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Renibus Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.